Type | Specific condition | Age (relative to reference age) | Relative risk (CI, if available) | Population risk (or reference risk) | Adjusted risk | References (first author's name only) |
Autosomal dominant | Achondroplasia | >50 (25 to 29) | 7.8 | 1/15,000 | 1/1923 | Risch[1] |
30 to 34 (<20) | 3.5 | 1/4285 | Tiemann-Boege[2] | |||
35 to 39 (<20) | 4 | 1/3750 | ||||
40 to 44 (<20) | 8 | 1/1875 | ||||
45 to 49 (<20) | 9 | 1/1666 | ||||
50 to 54 (<20) | 12 | 1/1250 | ||||
Apert | >50 (25 to 29) | 9.5 | 1/50,000 | 1/5263 | Risch[1] | |
Pfeiffer | >50 (25 to 29) | 6 | 1/100,000 | 1/16,666 | Glaser[3] | |
Crouzon | >50 (25 to 29) | 8 | 1/50,000 | 1/6250 | ||
Progeria | Unknown | Effect seen | "Exceedingly rare" | |||
MEN2A | Unknown | Effect seen | 1/30,000 | |||
MEN2B | Unknown | Effect seen | 1/30,000 | |||
Neurofibromatosis I | >50 (25 to 29) | 3.7* | 1/3000 to 1/4000 | 1/810 to 1/1080 | Risch[1] | |
>40 (<30) | 2.9 | 1/1034 to 1/1380 | Bunin[4] | |||
Osteogenesis imperfecta | >35 (<25) | 2.5 | 1/10,000 | 1/4000 | Carothers[5] | |
>35 (<35) | 1.37 (0.73 to 6.89) | 1/7300 | Orioli[6] | |||
Thanatophoric dysplasia | >35 (<35) | 3.18 (1.48 to 6.89) | 1/20,000 to 1/50,000 | 1/6290 to 1/15,723 | Orioli[6] | |
Retinoblastoma | >45 | 3* (0.21 to 41.7) | 1/15,000 to 1/20,000 | 1/5000 to 1/6667 | Dockerty, Yip[7,8] | |
>35 (<35) | 1.34 (1.04 to 1.74) | 1/11,200 to 1/14,925 | Moll[9] | |||
>50 (32.5) | 5 | 1/3000 to 1/4000 | DerKinderen[10] | |||
Chromosomal | Down syndrome | 40 to 44 (20 to 29) | 1.37 (0.48 to 3.86) | 1/1200 (maternal age 20 to 29) | 1/876 | Zhu[11] |
45 to 49 (20 to 29) | 2.68 (0.76 to 9.51) | 1/448 | ||||
>49 (20 to 29) | 4.5 (1.0 to 20.3) | 1/267 | ||||
40 to 44 (25 to 29) | 1.45 (1.26 to 1.68) | Use maternal age as baseline for counseling purposes¶ | Yang[12] | |||
45 to 49 (25 to 29) | 1.28 (1.04 to 1.57) | |||||
>49 (25 to 29) | 1.39 (1.04 to 1.83) | |||||
None given | "May be increased" | Kuhnert[13] | ||||
None given | "Paternal age effect in association with maternal age (>35) effect" | Fisch[14] | ||||
Klinefelter syndrome | >50 (20s) | 1.6Δ (0.69 to 3.0) | 1/500 men | 1/312 men | Lowe[15] | |
Congenital anomalies | VSD | >40 (<40) | 1.69* | 1/200 | 1/118 | Olshan[16] |
ASD | >35 | 1.95* | 1/400 | 1/205 | Lian[17] | |
Tracheoesophageal fistula | >50 (25 to 29) | 2.55 (1.28 to 4.6) | 1/3600 | 1/1412 | Yang[12] | |
Other complex disorders | Childhood leukemia | >35 | 1.5 | 1/25,000 | 1/16,667 | Murray[18] |
>40 (<25) | 1.14 (0.85 to 1.53) | 1/21,930 | Yip[8] | |||
Childhood CNS tumor | 30 to 34 (<25) | 1.34 (1.04 to 1.72) | 1/36,000 | 1/26,866 | Yip[8] | |
35 to 39 (<25) | 1.4 (1.04 to 1.86) | 1/25,714 | ||||
>40 (<25) | 1.69 (1.21 to 2.35) | 1/21,302 | ||||
Childhood type 1 diabetes | >34 (<25) | 1.52 (1.1 to 2.09) | 1/415 | 1/273 | Cardwell[19] | |
Epilepsy | 35 to 39 | 1.18 (1.02 to 1.26) | 1/100 | 1/85 | Vestergaard[20] | |
40 to 45 | 1.3 (1.08 to 1.55) | 1/770 | ||||
Schizophrenia | >50 (20 to 24) | 4.62 (2.28 to 9.36) | 1/100 | 1/22 | Rasmussen[21] | |
35 to 44 (15 to 24) | 1.6 (1.0 to 2.6) | 1/62.5 | Zammit[22] | |||
45 to 54 (15 to 24) | 1.6 (0.8 to 3.1) | 1/62.5 | ||||
>54 (15 to 24) | 3.8 (1.3 to 11.8) | 1/26 | ||||
>49 (<25) | 3 | 1/33 | Malaspina[23] | |||
>32 (<28) | 3 (1.49 to 6.04) | 1/33 | Tsuchiya[24] | |||
Autism | >40 (<30) | 5.75 (2.65 to 12.46) | 1/1000 | 1/174 | Reichenberg[25] | |
Unknown | Effect seen | Cantor[26] | ||||
Autism spectrum disorders | 35 to 39 (25 to 29) | 1.38 (1.04 to 1.84) | 1/200 | 1/145 | Croen[27] | |
>39 (25 to 29) | 1.52 (1.1 to 2.1) | 1/131 | ||||
Breast cancer | >40 (<30) | 1.6 (1.04 to 2.32) | 1/8.5 | 1/5.3 | Choi[28] | |
Prostate cancer | >38 (<27) | 1.7 (1.0 to 2.8) | 1/5.9 | 1/3.5 | Zhang[29] | |
Multiple sclerosis | 51 to 55 (21 to 25) | 2.0 (1.35 to 2.96) | Montgomery[30] | |||
Other | Spontaneous miscarriages | >35 (<35) | 1.26 (1.0 to 1.6) | 1/7 | 1/5.3 | Slama[31] |
>39 (25 to 29) | 1.6 (1.2 to 2.0) | 1/4 | Kleinhaus[32] | |||
Relative infertility | >39 (<39) | 2.3 (1.67 to 3.17) | 1/14 couples | 1/6.2 | De la Rochebrochard[33] | |
Low birth weight | >34 (20 to 34) | 1.7 (1.3 to 2.2) | 1/40 | 1/23 | Reichman[34] | |
Preeclampsia | 35 to 44 (25 to 34) | 1.24 (1.05 to 1.46) | 1/62 | 1/50 | Harlap[35] | |
>44 (25 to 34) | 1.8 (1.04 to 1.51) | 1/62 | 1/34 | |||
Total risk | For 86 examined congenital anomalies | >40 (<20) | 1.2 | 1/50 | 1/42 | Lian[17] |
>50 (<20) | 1.3 | 1/38 |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟